Literature DB >> 28646017

RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.

Ye Sun1, Chi-Hsiu Liu1, Zhongxiao Wang1, Steven S Meng1, Samuel B Burnim1, John Paul SanGiovanni2,3, Theodore M Kamenecka4, Laura A Solt5, Jing Chen6.   

Abstract

Pathological proliferation of retinal blood vessels commonly causes vision impairment in proliferative retinopathies, including retinopathy of prematurity. Dysregulated crosstalk between the vasculature and retinal neurons is increasingly recognized as a major factor contributing to the pathogenesis of vascular diseases. Class 3 semaphorins (SEMA3s), a group of neuron-secreted axonal and vascular guidance factors, suppress pathological vascular growth in retinopathy. However, the upstream transcriptional regulators that mediate the function of SEMA3s in vascular growth are poorly understood. Here we showed that retinoic acid receptor-related orphan receptor α (RORα), a nuclear receptor and transcription factor, is a novel transcriptional regulator of SEMA3E-mediated neurovascular coupling in a mouse model of oxygen-induced proliferative retinopathy. We found that genetic deficiency of RORα substantially induced Sema3e expression in retinopathy. Both RORα and SEMA3E were expressed in retinal ganglion cells. RORα directly bound to a specific ROR response element on the promoter of Sema3e and negatively regulated Sema3e promoter-driven luciferase expression. Suppression of Sema3e using adeno-associated virus 2 carrying short hairpin RNA targeting Sema3e promoted disoriented pathological neovascularization and partially abolished the inhibitory vascular effects of RORα deficiency in retinopathy. Our findings suggest that RORα is a novel transcriptional regulator of SEMA3E-mediated neurovascular coupling in pathological retinal angiogenesis.-Sun, Y., Liu, C.-H., Wang, Z., Meng, S. S., Burnim, S. B., SanGiovanni, J. P., Kamenecka, T. M., Solt, L. A., Chen, J. RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis. © FASEB.

Entities:  

Keywords:  SEMA3E; neovascularization; nuclear receptor; retinopathy

Mesh:

Substances:

Year:  2017        PMID: 28646017      PMCID: PMC5602899          DOI: 10.1096/fj.201700172R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  62 in total

Review 1.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

2.  Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration.

Authors:  Kaori Ueda; Tsutomu Nakahara; Maya Hoshino; Asami Mori; Kenji Sakamoto; Kunio Ishii
Journal:  Neurosci Lett       Date:  2010-08-27       Impact factor: 3.046

3.  Retinoid-related orphan receptor α is involved in induction of semaphorin 3A expression in normal human epidermal keratinocytes.

Authors:  Yayoi Kamata; Mitsutoshi Tominaga; Azumi Sakaguchi; Yoshie Umehara; Osamu Negi; Hideoki Ogawa; Kenji Takamori
Journal:  J Dermatol Sci       Date:  2015-04-02       Impact factor: 4.563

4.  staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice.

Authors:  M Steinmayr; E André; F Conquet; L Rondi-Reig; N Delhaye-Bouchaud; N Auclair; H Daniel; F Crépel; J Mariani; C Sotelo; M Becker-André
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

5.  Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.

Authors:  Jing Chen; Kip M Connor; Christopher M Aderman; Keirnan L Willett; Oskar P Aspegren; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

6.  Semaphorin 3F forms an anti-angiogenic barrier in outer retina.

Authors:  Anima Buehler; Nicholas Sitaras; Sandra Favret; Felicitas Bucher; Stefanie Berger; Amelie Pielen; Jean-Sebastian Joyal; Aimee M Juan; Gottfried Martin; Guenther Schlunck; Hansjürgen T Agostini; Michael Klagsbrun; Lois E H Smith; Przemyslaw Sapieha; Andreas Stahl
Journal:  FEBS Lett       Date:  2013-04-18       Impact factor: 4.124

Review 7.  Interrelationships between the Retinal Neuroglia and Vasculature in Diabetes.

Authors:  Timothy S Kern
Journal:  Diabetes Metab J       Date:  2014-06       Impact factor: 5.376

8.  Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling.

Authors:  Eun-Jin Kim; Young-Gun Yoo; Woo-Kyeom Yang; Young-Soun Lim; Tae-Young Na; In-Kyu Lee; Mi-Ock Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-24       Impact factor: 8.311

9.  Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Authors:  Laura A Solt; Naresh Kumar; Philippe Nuhant; Yongjun Wang; Janelle L Lauer; Jin Liu; Monica A Istrate; Theodore M Kamenecka; William R Roush; Dušica Vidović; Stephan C Schürer; Jihong Xu; Gail Wagoner; Paul D Drew; Patrick R Griffin; Thomas P Burris
Journal:  Nature       Date:  2011-04-17       Impact factor: 49.962

10.  Regulation of p53 stability and apoptosis by a ROR agonist.

Authors:  Yongjun Wang; Laura A Solt; Douglas J Kojetin; Thomas P Burris
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

View more
  8 in total

Review 1.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

2.  Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating β-catenin-dependent vascular remodeling.

Authors:  Dan-Yang Chen; Ning-He Sun; Xiang Chen; Jun-Jie Gong; Song-Tao Yuan; Zi-Zhong Hu; Nan-Nan Lu; Jakob Körbelin; Kohji Fukunaga; Qing-Huai Liu; Ying-Mei Lu; Feng Han
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

Review 3.  Expression of Genes Involved in Axon Guidance: How Much Have We Learned?

Authors:  Sung Wook Kim; Kyong-Tai Kim
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 4.  Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases.

Authors:  Pei-Li Yao; Jeremy Peavey; Goldis Malek
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

5.  Identification of a novel heterozygous missense mutation of SEMA3E (c.1327G>A; p. Ala443Thr) in a labor induced fetus with CHARGE syndrome.

Authors:  Xiao Song; Xueyan Wang; Li Ding; Dan He; Jin Sun; Na Xi; Yan Yin; Hui Peng; Lingling Sun
Journal:  Mol Genet Genomic Med       Date:  2019-11-06       Impact factor: 2.183

6.  Mesenchymal Stromal Cells Promote Retinal Vascular Repair by Modulating Sema3E and IL-17A in a Model of Ischemic Retinopathy.

Authors:  Baraa Noueihed; José Carlos Rivera; Rabah Dabouz; Pénélope Abram; Samy Omri; Isabelle Lahaie; Sylvain Chemtob
Journal:  Front Cell Dev Biol       Date:  2021-01-21

Review 7.  Targeting Neurovascular Interaction in Retinal Disorders.

Authors:  Zhongjie Fu; Ye Sun; Bertan Cakir; Yohei Tomita; Shuo Huang; Zhongxiao Wang; Chi-Hsiu Liu; Steve S Cho; William Britton; Timothy S Kern; David A Antonetti; Ann Hellström; Lois E H Smith
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

8.  Vascular Sema3E-Plexin-D1 Signaling Reactivation Promotes Post-stroke Recovery through VEGF Downregulation in Mice.

Authors:  Ri Yu; Nam-Suk Kim; Yan Li; Jin-Young Jeong; Sang-Joon Park; Bin Zhou; Won-Jong Oh
Journal:  Transl Stroke Res       Date:  2021-05-12       Impact factor: 6.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.